Professor Jennifer Martin inducted into Australian Academy of Health and Medical Sciences
Professor Jennifer Martin (FRACP, PhD) is being inducted into the Australian Academy of Health and Medical Sciences as a Fellow this week in recognition of her contribution made to health and medical research in Australia, in the area of clinical pharmacology research and education and clinical medicine.
Professor Martin is a practicing general physician and clinical pharmacologist in the Hunter New England Local Health District and Chair of Clinical Pharmacology at the University of Newcastle. She holds an MA in politics and economics from Oxford University, a basic science PhD from Monash University where she researched pharmacological pathways for drug development and use in cardiovascular disease and diabetes, followed by a postdoctoral fellowship at the Walter and Eliza Hall Institute.
"For me, being inducted is validation that our research and translation into practice is valued by the health and medical research scale, on a national level and recognition of the importance of our research program in national drug development and drug repurposing program. It is also awareness of the mandate our team has to keep stepping up with the research leadership, and the importance of clinical pharmacology to research programs and to clinical practice in the hospital and community setting."
Professor Martin is currently the Director of the Australian Centre for Cannabinoid Clinical and Research Excellence (ACRE), a National Health and Medical Research Council Centre of Research Excellence researching cannabinoid therapies and the appropriately balanced implementation of medicinal cannabinoid uptake into specialist and primary health care settings, leads a $2million Cancer Council Pathways grant for NSW around repurposed and individualised dosing of chemotherapies, and is Chief Investigator of two current MRFF Projects in cancer.
She is the Director of Centre for Drug Repurposing and Medical Research, which is developing a future program to reinvigorate therapeutics manufacturing and production around repurposed therapies. She is also currently leading several state and national clinical pharmacology trials with repurposed therapies in cancer of patients with unmet treatment needs.
“As a public servant I’m employed to deliver quality medical care. I aim to ensure my research and teaching contributes to delivering the best care; to contribute to a well trained next generation of medical practitioners and to enable the best use of public investment in pharmaceutical development and accessibility to patients.”
As well as practicing medicine, she has been involved in a broad range of activities including State, Commonwealth and international medicines and Government health policy committees/advisory roles, specifically around drug development and translation into optimised medicines usage. She is also a Director on the Royal Australasian College of Physicians Board of Directors, the University of Newcastle Council and the NSW Council of the Australian Institute of Company Directors.